ArticleFrontiers in oncology2026
Pulmonary artery sarcoma masquerading as pulmonary embolism: the pivotal role of sonographic differentiation - a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary artery sarcoma (PAS) is a rare and highly aggressive malignancy. It often presents with nonspecific clinical symptoms and is frequently misdiagnosed as pulmonary embolism (PE). Studies suggest that approximately 50% of PAS cases are initially misdiagnosed as PE. The discovery in this case report was an incidental finding. We describe the case of a patient admitted with chest tightness and chest pain. Due to a history of coronary stent implantation for 10 years, acute coronary syndrome was initially considered. Echocardiography was carried out primarily to assess cardiac condition. However, the examination revealed a hypoechoic mass in the main pulmonary artery with morphological features atypical for PE. Computed tomography angiography (CTA) was therefore recommended for further evaluation. Although the initial CTA interpretation suggested PE, the discordance between the echocardiographic and CT findings prompted the immediate initiation of anticoagulation therapy alongside a concurrent multidisciplinary consultation. The consensus following the discussion indicated a high probability of PAS. The patient subsequently underwent surgery at another hospital, and the postoperative pathology confirmed PAS. To our knowledge, current reports on PAS focus predominantly on findings from CTA, MRI, and PET-CT, while echocardiographic features are often only mentioned cursorily. However, echocardiography offers a unique capability for dynamic assessment of the tumor, which is not available with other imaging modalities. The aim of this report is to enhance the understanding of the echocardiographic manifestations of PAS, thereby facilitating earlier detection and potentially creating opportunities for surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.